Corrigendum: Exogenous ketone supplements reduce anxiety-related behavior in sprague-dawley and wistar albino glaxo/rijswijk ratse (Front. Mol. Neurosci. (2016) 9:137. doi: 10.3389/fnmol.2016.00137);Exogenous Ketone supplements reduce anxiety-related behavior in Sprague-Dawley and Wistar Albino Glaxo/Rijswijk rats

Frontiers in Molecular Neuroscience

Volumn 9, Issue DEC2016, 2016, Pages

  Ari, Csilla ^a   Kovács, Zsolt ^b   Juhasz, Gabor ^c   Murdun, Cem ^a   Goldhagen, Craig R ^a   Koutnik, Andrew M ^a   Poff, Angela M ^a   Kesl, Shannon L ^a   D’Agostino, Dominic P ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF WEST HUNGARY   (Hungary)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

Animal models; Anxiety; Elevated plus maze; Exogenous ketone supplements; Ketones

Indexed keywords

KETONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT; DIET RESTRICTION; ELEVATED PLUS MAZE TEST; KETOACIDOSIS; LATENT PERIOD; MALE; MOUSE; NONHUMAN; RAT;

EID: 85007414682     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2017.00036     Document Type: Erratum

References (67)

1. Albert, C. M., Chae, C. U., Rexrode, K. M., Manson, J. E., and Kawachi, I. (2005). Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation 111, 480-487. doi:10.1161/01.cir.0000153813.64165.5d
2. Barnett, S. A. (1975). The Rat-A Study in Behavior. Chicago, IL: University of Chicago Press.
3. Bough, K. J., and Rho, J. M. (2007). Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 48, 43-58. doi:10.1111/j.1528-1167.2007.00915.x
4. Brunengraber, H. (1997). Potential of ketone body esters for parenteral and oral nutrition. Nutrition 13, 233-235. doi:10.1016/s0899-9007(96)00409-1
5. Ciarlone, S. L., Grieco, J. C., D’Agostino, D. P., and Weeber, E. J. (2016). Ketone ester supplementation attenuates seizure activity and improves behavior and hippocampal synaptic plasticity in an Angelman syndrome mouse model. Neurobiol. Dis. 96, 38-46. doi:10.1016/j.nbd.2016.08.002
6. Ciraolo, S. T., Previs, S. F., Fernandez, C. A., Agarwal, K. C., David, F., Koshy, J., et al. (1995). Model of extreme hypoglycemia in dogs made ketotic with (R,S)-1,3-butanediol acetoacetate esters. Am. J. Physiol. 269, E67-E75.
7. Clarke, K., Tchabanenko, K., Pawlosky, R., Carter, E., Todd King, M., Musa-Veloso, K., et al. (2012). Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regul. Toxicol. Pharmacol. 63, 401-408. doi:10.1016/j.yrtph.2012.04.008
8. Coenen, A. M. L., and Van Luijtelaar, E. L. J. M. (2003). Genetic animal models for absence epilepsy: a review of the WAG/Rij strain of rats. Behav. Genet. 33, 635-655. doi:10.1023/A:1026179013847
9. D’Agostino, D. P., Pilla, R., Held, H. E., Landon, C. S., Puchowicz, M., Brunengraber, H., et al. (2013). Therapeutic ketosis with ketone ester delays central nervous system oxygen toxicity seizures in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304, R829-R836. doi:10.1152/ajpregu.00506.2012
10. De Giorgis, V., and Veggiotti, P. (2013). GLUT1 deficiency syndrome 2013: current state of the art. Seizure 22, 803-811. doi:10.1016/j.seizure.2013.07.003
11. Desrochers, S., David, F., Garneau, M., Jetté, M., and Brunengraber, H. (1992). Metabolism of R-and S-1,3-butanediol in perfused livers from meal-fed and starved rats. Biochem. J. 285, 647-653. doi:10.1042/bj2850647
12. Desrochers, S., Quinze, K., Dugas, H., Dubreuil, P., Bomont, C., David, F., et al. (1995). R,S-1,3-butanediol acetoacetate esters, potential alternates to lipid emulsions for total parenteral nutrition. J. Nutr. Biochem. 6, 111-118. doi:10.1016/0955-2863(94)00011-a
13. Dias, B. G., Banerjee, S. B., Goodman, J. V., and Ressler, K. J. (2013). Towards new approaches to disorders of fear and anxiety. Curr. Opin. Neurobiol. 23, 346-352. doi:10.1016/j.conb.2013.01.013
14. Ehrenreich, M. J. (2006). A case of the re-emergence of panic and anxiety symptoms after initiation of a high-protein, very low carbohydrate diet. Psychosomatics 47, 178-179. doi:10.1176/appi.psy.47.2.178
15. Engin, E., and Treit, D. (2008). The effects of intra-cerebral drug infusions on animals’ unconditioned fear reactions: a systematic review. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 1399-1419. doi:10.1016/j.pnpbp.2008.03.020
16. Ferguson, S. A., and Gray, E. P. (2005). Aging effects on elevated plus maze behavior in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley male and female rats. Physiol. Behav. 85, 621-628. doi:10.1016/j.physbeh.2005.06.009
17. Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R., et al. (1999). The economic burden of anxiety disorders in the 1990s. J. Clin. Psychiatry 60, 427-435. doi:10.4088/jcp.v60n0702
18. Guimarães, F. S., Carobrez, A. P., De Aguiar, J. C., and Graeff, F. G. (1991). Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey. Psychopharmacology (Berl) 103, 91-94. doi:10.1007/bf02244080
19. Hamid, H., Ettinger, A. B., and Mula, M. (2011). Anxiety symptoms in epilepsy: salient issues for future research. Epilepsy Behav. 22, 63-68. doi:10.1016/j.yebeh.2011.04.064
20. Hartman, A. L., Gasior, M., Vining, E. P., and Rogawski, M. A. (2007). The neuropharmacology of the ketogenic diet. Pediatr. Neurol. 36, 281-292. doi:10.1016/j.pediatrneurol.2007.02.008
21. Herbert, M. R., and Buckley, J. A. (2013). Autism and dietary therapy case report and review of the literature. J. Child Neurol. 28, 975-982. doi:10.1177/0883073813488668
22. Johansson, B., Halldner, L., Dunwiddie, T. V., Masino, S. A., Poelchen, W., Giménez-Llort, L., et al. (2001). Hyperalgesia, anxiety and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl. Acad. Sci. U S A 98, 9407-9412. doi:10.1073/pnas.161292398
23. Kakui, N., Yokoyama, F., Yamauchi, M., Kitamura, K., Imanishi, T., Inoue, T., et al. (2009). Anxiolytic-like profile of mirtazapine in rat conditioned fear stress model: functional significance of 5-hydroxytryptamine 1A receptor and α1-adrenergic receptor. Pharmacol. Biochem. Behav. 92, 393-398. doi:10.1016/j.pbb.2008.12.022
24. Kesl, S., Poff, A., Ward, N., Fiorelli, T., Ari, C., Van Putten, A., et al. (2015). Effect of sustaining dietary ketosis on the hippocampal and serum metabolome of Sprague-Dawley rats. FASEB J. 29, Suppl. 745.4
25. Kesl, S. L., Poff, A. M., Ward, N. P., Fiorelli, T. N., Ari, C., Van Putten, A. J., et al. (2016). Effects of exogenous ketone supplementation on blood ketone, glucose, triglyceride, and lipoprotein levels in Sprague-Dawley rats. Nutr. Metab. (Lond) 13:9. doi:10.1186/s12986-016-0069-y
26. Kesl, S., Prather, J., Sherwood, J., Gould, L., and D’Agostino, P. D. (2014). Sustaining dietary ketosis to improve blood flow and wound healing in young and aged Fisher rats. FASEB J. 28:734.7, Suppl. 734.7
27. Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., and Walters, E. E. (2005). Prevalence, severity and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch. Gen. Psychiatry 62, 617-627. doi:10.1001/archpsyc.62.6.617
28. Klein, E., Zohar, J., Geraci, M. F., Murphy, D. L., and Uhde, T. W. (1991). Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine’s anxiogenic effects. Biol. Psychiatry 30, 973-984. doi:10.1016/0006-3223(91)90119-7
29. Klepper, J., and Voit, T. (2002). Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain-a review. Eur. J. Pediatr. 161, 295-304. doi:10.1007/s00431-002-0939-3
30. Kossoff, E. H., Freeman, J. M., Turner, Z., and Rubenstein, J. E. (2011). Ketogenic Diets: Treatments for Epilepsy and Otherdisorders. 5th Edn. New York, NY: Demos Medical.
31. Kovács, Z., Czurkó, A., Kékesi, K. A., and Juhász, G. (2012). Neonatal tricyclic antidepressant clomipramine treatment reduces the spike-wave discharge activity of the adultWAG/Rij rat. Brain Res. Bull. 89, 102-107. doi:10.1016/j.brainresbull.2012.07.010
32. Kovács, Z., and Dobolyi, A. (2013). “Anatomical distribution of nucleoside system in the human brain and implications for therapy,” in Adenosine: A Key Link Between Metabolism and Brain Activity, eds S. A. Masino and D. Boison (New York, NY: Springer Science, Business Media), 621-656.
33. Kovács, Z., Kékesi, K. A., Dobolyi, Á., Lakatos, R., and Juhász, G. (2015). Absence epileptic activity changing effects of non-adenosine nucleoside inosine, guanosine and uridine in Wistar Albino Glaxo Rijswijk rats. Neuroscience 300, 593-608. doi:10.1016/j.neuroscience.2015.05.054
34. Kovács, Z., Kékesi, K. A., Szilágyi, N., Abrahám, I., Székács, D., Király, N., et al. (2006). Facilitation of spike-wave discharge activity by lipopolysaccharides in Wistar Albino Glaxo/Rijswijk rats. Neuroscience 140, 731-742. doi:10.1016/j.neuroscience.2006.02.023
35. Kwiterovich, P. O. Jr., Vining, E., Pyzik, P., Skolasky, R. Jr., and Freeman, J. (2003). Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins and apolipoproteins in children. JAMA 290, 912-920. doi:10.1001/jama.290.7.912
36. Ledent, C., Vaugeois, J. M., Schiffmann, S. N., Pedrazzini, T., El Yacoubi, M., and Vanderhaeghen, J. J. (1997). Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388, 674-678. doi:10.1038/41771
37. Leen, W. G., Klepper, J., Verbeek, M. M., Leferink, M., Hofste, T., van Engelen, B. G., et al. (2010). Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 133, 655-670. doi:10.1093/brain/awp336
38. Li, X. (2012). Using the conditioned fear stress (CFS) animal model to understand the neurobiological mechanisms and pharmacological treatment of anxiety. Shanghai Arch. Psychiatry 24, 241-249. doi:10.3969/j.issn.1002-0829.2012.05.001
39. Luhmann, H. J., Mittmann, T., van Luijtelaar, G., and Heinemann, U. (1995). Impairment of intracortical GABAergic inhibition in a rat model of absence epilepsy. Epilepsy Res. 22, 43-51. doi:10.1016/0920-1211(95)00032-6
40. Lutas, A., and Yellen, G. (2013). The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci. 36, 32-40. doi:10.1016/j.tins.2012.11.005
41. Lynn, D. A., and Brown, G. R. (2010). The ontogeny of anxiety-like behavior in rats from adolescence to adulthood. Dev. Psychobiol. 52, 731-739. doi:10.1002/dev.20468
42. Masino, S. A., Kawamura, M. Jr., Ruskin, D. N., Geiger, J. D., and Boison, D. (2012). Purines and neuronal excitability: links to the ketogenic diet. Epilepsy Res. 100, 229-238. doi:10.1016/j.eplepsyres.2011.07.014
43. Mula, M. (2013). Treatment of anxiety disorders, in epilepsy: an evidence-based approach. Epilepsia 54, 13-18. doi:10.1111/epi.12101
44. Nagy, J., Zámbó, K., and Decsi, L. (1979). Anti-anxiety action of diazepam after intra-amygdaloid application in the rat. Neuropharmacology 18, 573-576. doi:10.1016/0028-3908(79)90104-7
45. Newport, M. T., VanItallie, T. B., Kashiwaya, Y., King, M. T., and Veech, R. L. (2015). A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer’s disease. Alzheimers Dement. 11, 99-103. doi:10.1016/j.jalz.2014.01.006
46. Owen, O. E., Morgan, A. P., Kemp, H. G., Sullivan, J. M., Herrera, M. G., and Cahill, G. F. Jr. (1967). Brain metabolism during fasting. J. Clin. Invest. 46, 1589-1595. doi:10.1172/JCI105650
47. Paslawski, T., Treit, D., Baker, G. B., George, M., and Coutts, R. T. (1996). The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA. Psychopharmacology (Berl) 127, 19-24. doi:10.1007/bf02805970
48. Pellow, S., Chopin, P., File, S. E., and Briley, M. (1985). Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14, 149-167. doi:10.1016/0165-0270(85)90031-7
49. Placidi, G. P. A., Oquendo, M. A., Malone, K. M., Brodsky, B., Ellis, S. P., and Mann, J. J. (2000). Anxiety in major depression: relationship to suicide attempts. Am. J. Psychiatry 157, 1614-1618. doi:10.1176/appi.ajp.157.10.1614
50. Poff, A. M., Ari, C., Arnold, P., Seyfried, T. N., and D’Agostino, D. P. (2014). Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer. Int. J. Cancer 135, 1711-1720. doi:10.1002/ijc.28809
51. Poff, A. M., Ari, C., Seyfried, T., and D’Agostino, D. (2013). The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer. PLoS One 8:e65522. doi:10.1371/journal.pone.0065522
52. Poff, A. M., Ward, N., Seyfried, T. N., Arnold, P., and D’Agostino, D. P. (2015). Non-toxic metabolic management of metastatic cancer in VM mice: novel combination of ketogenic diet, ketone supplementation and hyperbaric oxygen therapy. PLoS One 10:e0127407. doi:10.1371/journal.pone.0127407
53. Puchowicz, M. A., Smith, C. L., Bomont, C., Koshy, J., David, F., and Brunengraber, H. (2000). Dog model of therapeutic ketosis induced by oral administration of R,S-1,3-butanediol diacetoacetate. J. Nutr. Biochem. 11, 281-287. doi:10.1016/s0955-2863(00)00079-6
54. Rebuli, M. E., Camacho, L., Adonay, M. E., Reif, D. M., Aylor, D., and Patisaul, H. B. (2015). Impact of low dose oral exposure to bisphenol A (BPA) on juvenile and adult ratexploratory and anxiety behavior: a CLARITY-BPA consortium study. Toxicol. Sci. 148, 341-354. doi:10.1093/toxsci/kfv163
55. Rho, J. M. (2015). How does the ketogenic diet induce anti-seizure effects? Neurosci. Lett. doi:10.1016/j.neulet.2015.07.034
56. Sankar, R. (2012). GABAA receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam. CNS Drugs 26, 229-244. doi:10.2165/11599020-000000000-00000
57. Sarkisova, K. Y., and Kulikov, M. A. (2006). Behavioral characteristics of WAG/Rij rats susceptible and non-susceptible to audiogenic seizures. Behav. Brain Res. 166, 9-18. doi:10.1016/j.bbr.2005.07.024
58. Srivastava, S., Kashiwaya, Y., King, M., Baxa, U., Tam, J., Niu, G., et al. (2012). Mitochondrial biogenesis and increased uncoupling protein 1 in brown adipose tissue of mice fed a ketone ester diet. FASEB J. 26, 2351-2362. doi:10.1096/fj.11-200410
59. Sarkisova, K. Y., Midzianovskaia, I. S., and Kulikov, M. A. (2003). Depressive-like behavioral alterations and c-fos expression in the dopaminergic brain regions in WAG/Rij rats with genetic absence epilepsy. Behav. Brain Res. 144, 211-226. doi:10.1016/s0166-4328(03)00090-1
60. Sarkisova, K., and van Luijtelaar, G. (2011). The WAG/Rij strain: a genetic animal model of absence epilepsy with comorbidity of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 854-876. doi:10.1016/j.pnpbp.2010.11.010
61. Stahl, S. M. (2003). Brainstorms: symptoms and circuits, part 2: anxiety disorders. J. Clin. Psychiatry. 64, 1408-1409.
62. Teri, L., Ferretti, L. E., Gibbons, R. G., Logsdon, S. M., McCurry, W. A., Kukull, W. C., et al. (1999). Anxiety in Alzheimer’s disease: prevalence and comorbidity. J. Gerontol. A Biol. Sci. Med. Sci. 54, M348-M352. doi:10.1093/gerona/54.7.m348
63. Tu, W., Cook, A., Scholl, J. L., Mears, M., Watt, M. J., Renner, K. J., et al. (2014). Serotonin in the ventral hippocampus modulates anxiety-like behavior during amphetamine withdrawal. Neuroscience 281C, 35-43. doi:10.1016/j.neuroscience.2014.09.019
64. Veech, R. L. (2004). The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance and mitochondrial metabolism. Prostaglandins Leukot. Essent. Fatty Acids 70, 309-319. doi:10.1016/j.plefa.2003.09.007
65. Veggiotti, P., and De Giorgis, V. (2014). Dietary treatments and new therapeutic perspective in GLUT1 deficiency syndrome. Curr. Treat. Options Neurol. 16:291. doi:10.1007/s11940-014-0291-8
66. Walf, A. A., and Frye, C. A. (2007). The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc. 2, 322-328. doi:10.1038/nprot.2007.44
67. Yudkoff, M., Daikhin, Y., Melø, T. M., Nissim, I., Sonnewald, U., and Nissim, I. (2007). The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect. Annu. Rev. Nutr. 27, 415-430. doi:10.1146/annurev.nutr.27.061406.093722